The cDNA encoding G(M2) activator was expressed in the Escherichia col
i/pT7-7 system. The yield of the G(M2) activator with greater than 99%
purity was about 3 mg per liter culture. The recombinant G(M2) activa
tor was found to be as active as that isolated from human kidney. The
availability of the recombinant G(M2) activator enabled us to critical
ly examine the specificity of this activator protein. Our results show
that the specificity of G(M2) activator is not as strict as that repo
rted previously. Although G(M2) activator stimulates most efficiently
the degradation of G(M2) carried out by beta-N-acetylhexosaminidase A
(Hex A), this activator also stimulates the following reactions: (a) c
onversion of G(M2) to G(A2) by clostridial sialidase; (b) hydrolysis o
f GalNAc from lmitoylphosphatidylethanolamine-II(3)NeuAcGgOse(3) by He
x A; and (c) liberation of Gal from G(M1) by beta-galactosidase at a h
igh activator concentration. Thus, this activator does not differentia
te between G(M2) and lmitoylphosphatidylethanolamine-II(3)NeuAcGgOse(3
) or between Hex A and clostridial sialidase. The micellar forms of G(
D2) and GalNAc-G(D1a) were found to be more readily hydrolyzed by Hex
A than G(M2) in the absence of G(M2) activator. Our results also show
that saposin B can enhance the stimulatory activity of G(M2) activator
, but it cannot promote the stimulatory activity of sodium taurodeoxyc
holate. Taken together, our results suggest that the mechanism of acti
on of G(M2) activator is different from saposin B, and the action of G
(M2) activator is more than to solubilize lipid substrates. The effect
iveness of G(M2) activator in stimulating the hydrolysis of G(M2) may
be due to its abil ity to recognize the specific trisaccharide structu
re of the G(M2) epitope, GalNAc beta 1 --> 4(NeuAc alpha 2 --> 3)Gal-,
and to modify the GalNAc-NeuAc interaction in this structure.